RPL5 and Diamond-Blackfan anemia: Nine out of ten eligible DBA patients respond to glucocorticoid treatment, one-quarter of patients become steroid-dependent (especially patients with variants in RPL5, RPL11, and RPS24 genes), and 11–25% of patients achieve remission spontaneously [3,45].